Home > News

NEWS

Here you will find information on Norameda’s activities, as well as news related to the pharmaceutical industry.
The Chiesi Group chooses Norameda

The Chiesi Group chooses Norameda

Leber’s Hereditary Optic Neuropathy (LHON) – a devastating diagnosis. It is a heritable genetic disease causing profound vision loss and blindness. Unfortunately, there is no cure. And ways of treatment are limited. The disease presents predominantly in young,...

read more